NO973243D0 - Use of 3,4-diphenylchromanes in the preparation of a pharmaceutical preparation for the treatment or prophylaxis of gynecological diseases - Google Patents

Use of 3,4-diphenylchromanes in the preparation of a pharmaceutical preparation for the treatment or prophylaxis of gynecological diseases

Info

Publication number
NO973243D0
NO973243D0 NO973243A NO973243A NO973243D0 NO 973243 D0 NO973243 D0 NO 973243D0 NO 973243 A NO973243 A NO 973243A NO 973243 A NO973243 A NO 973243A NO 973243 D0 NO973243 D0 NO 973243D0
Authority
NO
Norway
Prior art keywords
preparation
diphenylchromanes
prophylaxis
treatment
gynecological diseases
Prior art date
Application number
NO973243A
Other languages
Norwegian (no)
Other versions
NO973243L (en
Inventor
Martin William Edwards
James Robertson Piggott
Virender Mohan Labroo
Ved Prakash Kamboj
Suprabhat Ray
Niels Korsgaard
Michael Shalmi
Birgitte Hjort Guldhammer
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of NO973243L publication Critical patent/NO973243L/en
Publication of NO973243D0 publication Critical patent/NO973243D0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
NO973243A 1995-01-13 1997-07-11 Use of 3,4-diphenylchromanes in the preparation of a pharmaceutical preparation for the treatment or prophylaxis of gynecological diseases NO973243D0 (en)

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
DK4495 1995-01-13
DK4695 1995-01-13
DK4795 1995-01-13
DK4595 1995-01-13
DK4895 1995-01-13
DK77295 1995-06-30
DK77195 1995-06-30
DK77095 1995-06-30
DK76895 1995-06-30
DK76995 1995-06-30
PCT/DK1996/000015 WO1996021444A1 (en) 1995-01-13 1996-01-10 Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of gynaecological disorders

Publications (2)

Publication Number Publication Date
NO973243L NO973243L (en) 1997-07-11
NO973243D0 true NO973243D0 (en) 1997-07-11

Family

ID=27579214

Family Applications (1)

Application Number Title Priority Date Filing Date
NO973243A NO973243D0 (en) 1995-01-13 1997-07-11 Use of 3,4-diphenylchromanes in the preparation of a pharmaceutical preparation for the treatment or prophylaxis of gynecological diseases

Country Status (11)

Country Link
EP (1) EP0804190A1 (en)
JP (1) JPH10511962A (en)
CN (1) CN1168096A (en)
AU (1) AU693628B2 (en)
CA (1) CA2208861A1 (en)
CZ (1) CZ212297A3 (en)
HU (1) HUP9702244A3 (en)
IL (1) IL116746A0 (en)
MX (1) MX9705219A (en)
NO (1) NO973243D0 (en)
WO (1) WO1996021444A1 (en)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5994390A (en) * 1996-10-28 1999-11-30 Novo Nordisk Trans-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
ATE231141T1 (en) * 1996-10-28 2003-02-15 Novo Nordisk As (-)-ENANTIOMERS OF CIS-3,4-CHROMAN DERIVATIVES FOR THE PREVENTION OR TREATMENT OF ESTROGEN-RELATED DISEASES OR SYNDROMES
DK0937060T3 (en) * 1996-10-28 2003-04-07 Novo Nordisk As New cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen-related diseases or syndromes
US6316494B1 (en) 1996-10-28 2001-11-13 Novo Nordisk A/S cis3, 4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
JP2001502710A (en) * 1996-10-28 2001-02-27 ノボ ノルディスク アクティーゼルスカブ Novel cis-3,4-chroman derivatives useful for prevention or treatment of estrogen-related diseases or syndromes
US5919817A (en) * 1996-10-28 1999-07-06 Novo Nordisk A/S Cis-3, 4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
ZA979650B (en) * 1996-10-28 1998-04-28 Novo Nordisk As Heterocyclic compounds, compositions and uses.
IL129617A0 (en) * 1996-10-28 2000-02-29 Novo Nordisk As Novel CIS-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
ZA979644B (en) * 1996-10-28 1998-04-28 Novo Nordisk As Heterocyclic compounds, compositions and uses.
ZA979643B (en) * 1996-10-28 1998-04-28 Novo Nordisk As Heterocyclic compounds, compositions and uses.
AU4700097A (en) * 1996-10-28 1998-05-22 Novo Nordisk A/S Novel (cis)-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
US5958967A (en) * 1996-10-28 1999-09-28 Novo Nordisk A/S Cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
WO1998018772A1 (en) * 1996-10-28 1998-05-07 Novo Nordisk A/S NOVEL cis-3,4-CHROMAN DERIVATIVES USEFUL IN THE PREVENTION OR TREATMENT OF ESTROGEN RELATED DISEASES OR SYNDROMES
US5985306A (en) * 1996-10-28 1999-11-16 Novo Nordisk A/S (+)-enantiomers of cis-3,4-chroman derivatives useful in prevention or treatment of estrogen diseases or syndromes
US6043269A (en) * 1996-10-28 2000-03-28 Novo Nordisk A/S cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
US7214706B2 (en) 2000-03-01 2007-05-08 Akzo Nobel N.V. Chroman derivatives as estrogenic compounds
MX2007003216A (en) 2004-09-21 2008-03-10 Novogen Res Pty Ltd Substituted chroman derivatives, medicaments and use in therapy.
US8080675B2 (en) 2004-09-21 2011-12-20 Marshall Edwards, Inc. Chroman derivatives, medicaments and use in therapy
US9663484B2 (en) 2010-11-01 2017-05-30 Mei Pharma, Inc. Isoflavonoid compounds and methods for the treatment of cancer
US9701655B2 (en) 2014-02-07 2017-07-11 Novogen Limited Functionalised benzopyran compounds and use thereof
PT3253208T (en) 2015-02-02 2021-06-17 The Spanish National Cancer Res Centre Combination therapies

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5407955A (en) * 1994-02-18 1995-04-18 Eli Lilly And Company Methods for lowering serum cholesterol and inhibiting smooth muscle cell proliferation, restenosis, endometriosis, and uterine fibroid disease

Also Published As

Publication number Publication date
HUP9702244A3 (en) 1999-12-28
NO973243L (en) 1997-07-11
AU693628B2 (en) 1998-07-02
AU4329396A (en) 1996-07-31
MX9705219A (en) 1997-10-31
CA2208861A1 (en) 1996-07-18
JPH10511962A (en) 1998-11-17
IL116746A0 (en) 1996-05-14
HUP9877967A2 (en) 1998-12-28
CN1168096A (en) 1997-12-17
WO1996021444A1 (en) 1996-07-18
CZ212297A3 (en) 1997-11-12
EP0804190A1 (en) 1997-11-05

Similar Documents

Publication Publication Date Title
NO973243D0 (en) Use of 3,4-diphenylchromanes in the preparation of a pharmaceutical preparation for the treatment or prophylaxis of gynecological diseases
NO961006D0 (en) Phosphonomononucleic acids, processes for their preparation and use of the compounds
ATE252901T1 (en) MEDICINAL PRODUCTS FOR THE TREATMENT OF INFLAMMATORY HEART DISEASE
CY2007001I2 (en) MEDICINAL PREPARATION FOR USE IN THE TREATMENT OF DIABETES
EE9600019A (en) 2,8-Disubstituted quinazolinones, process for their preparation, use in the manufacture of medicaments and medicaments containing these compounds
NO910828D0 (en) PREPARATION FOR THE TREATMENT OF ERECTIVE FUNCTIONAL FAILURE.
NO892826D0 (en) PROCEDURE FOR THE PREPARATION OF A PHARMACEUTICAL PREPARATION FOR AA PREVENT SEXUALLY TRANSFERABLE DISEASES.
ITRM920412A1 (en) HETEROPROSTANOIDS, PROCEDURE FOR THEIR PREPARATION AND THERAPEUTIC USE.
AU4048295A (en) Peptide medicaments for the treatment of disease
NO961742D0 (en) Use of retinoids in a cosmetic composition or in the manufacture of a pharmaceutical composition
NO981800D0 (en) Process for the preparation of 1,1,1,3,3-pentafluoropentane
EE9600018A (en) 2,9-Disubstituted purin-6-ones, process for their preparation, use in the manufacture of medicaments and medicaments containing these compounds
EE03878B1 (en) 5-O-Desosaminyl-6-O-methylerythronolide A Derivatives, Process for their Preparation and Use in the Preparation of Bioactive Compounds
NO973342D0 (en) Use of 3,4-diphenylchromanes in the preparation of a pharmaceutical composition for the treatment or prophylaxis of cerebral degenerative diseases
DE69108143T2 (en) Rotogranulates and flavor-covering coatings for the manufacture of pharmaceutical chewable tablets.
NO973610D0 (en) New pharmaceutical preparation
NO973340D0 (en) Use of 3,4-diphenylchromanes in the preparation of a pharmaceutical composition for the treatment or prophylaxis of obesity
NO991164D0 (en) Pharmaceutical surface preparation for the treatment of viral diseases
NO973341D0 (en) Use of 3,4-diphenylchromanes in the preparation of a pharmaceutical preparation for vasodilatory treatment or prophylaxis
NO913162L (en) PHARMACEUTICAL PREPARATION FOR TONSILLITE TREATMENT.
FI951759A0 (en) Process for the preparation of 2,2-difluorokethylsilyl-O, S-acetals and O, S-esters of alpha, alpha-difluoro-beta-silyloxy-1,3-dioxolane-4-propanoic acid
NO973611D0 (en) New pharmaceutical preparation
NO973242D0 (en) Use of 3,4-diphenylchromanes for the preparation of a pharmaceutical composition for the treatment or prophylaxis of idiopathic or physiological gynecomastia
NO950950D0 (en) Pharmaceutical preparation
NO903939L (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE CONDENSED DIAZEPINONES.